Amarin Corp Plcuk (AMRN) Gross Profit Growth (1y) (2014 - 2026)
Amarin Corp Plcuk (AMRN) Gross Profit Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 7.10% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 14.64% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -0.30% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -2.37% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 7.32% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 17.43% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 11.52% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.62% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 6.14% |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | -70.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -70.24% |
| Mar 31, 2026 | -29.29% |
| Dec 31, 2025 | 342.18% |
| Sep 30, 2025 | 36.45% |
| Jun 30, 2025 | 17.75% |
| Mar 31, 2025 | -21.23% |
| Dec 31, 2024 | -121.20% |
| Sep 30, 2024 | -45.42% |
| Jun 30, 2024 | 0.24% |
| Mar 31, 2024 | -33.43% |
| Dec 31, 2023 | -29.05% |
| Sep 30, 2023 | -52.56% |
| Jun 30, 2023 | -2.20% |
| Mar 31, 2023 | -33.79% |
| Dec 31, 2022 | -44.14% |
| Sep 30, 2022 | -43.79% |
| Jun 30, 2022 | -64.34% |
| Mar 31, 2022 | -36.41% |
| Dec 31, 2021 | -14.06% |
| Sep 30, 2021 | -9.40% |